Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Invictus MD Strategies Corp IVITF

Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II expansion and received its amended license from Health Canada. Another of its wholly owned subsidiary, connects medical clients to physicians for medical cannabis.


GREY:IVITF - Post by User

Post by frankmanon Jan 07, 2020 9:44am
150 Views
Post# 30525386

Decrease in sales and marketing expense by 18%

Decrease in sales and marketing expense by 18%Decrease in sales and marketing expense by 18% is primarily due to greater sales and marketing activities associated with several launches and go-to-market initiatives in order to have the requisite marketing and sales assets in place for deployment commensurate with product availability, in the prior year. The sales and marketing expense for the nine months ended October 31, 2019 primarily consists of a $5.9 million termination fee related to a brand licensing agreement with guaranteed minimum royalty payments with ABGHMX, LLC. The Company expects lower sales and marketing expense going forward.

Sales and marketing expense October 31, 2019  $ 7,813,278
                                                 October 31, 2018  $ 9,470,969
<< Previous
Bullboard Posts
Next >>